{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:59:52Z","timestamp":1777636792718,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jacl.2023.07.002","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T12:05:09Z","timestamp":1689595509000},"page":"700-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of cerebrotendinous xanthomatosis in pregnancy: Patient and physician perspectives"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-5154","authenticated-orcid":false,"given":"P. Barton","family":"Duell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hollisa","family":"Rosengrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jacl.2023.07.002_bib0001","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacl.2018.06.008","article-title":"Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis","volume":"12","author":"Duell","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2023.07.002_bib0002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13023-021-01980-5","article-title":"Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study","volume":"16","author":"Stelten","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.jacl.2023.07.002_bib0003","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","article-title":"Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)","volume":"40","author":"Salen","year":"2017","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.jacl.2023.07.002_bib0004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13023-022-02578-1","article-title":"Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis","volume":"18","author":"Pramparo","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.jacl.2023.07.002_bib0005","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/GIM.0b013e31818d0e0f","article-title":"Population screening in a Druze community: the challenge and the reward","volume":"10","author":"Falik-Zaccai","year":"2008","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.jacl.2023.07.002_bib0006","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymgme.2015.10.010","article-title":"Apparent underdiagnosis of Cerebrotendinous xanthomatosis revealed by analysis of \u223c60,000 human exomes","volume":"116","author":"Appadurai","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.jacl.2023.07.002_bib0007","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOL.0000000000000740","article-title":"Update on cerebrotendinous xanthomatosis","volume":"32","author":"DeBarber","year":"2021","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2023.07.002_bib0008","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10545-013-9674-3","article-title":"A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis","volume":"37","author":"Mignarri","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"26","key":"10.1016\/j.jacl.2023.07.002_bib0009","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","article-title":"Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid","volume":"311","author":"Berginer","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2023.07.002_bib0010","unstructured":"U.S. Food and Drug Administration. Orphan drug designations and approvals: treatment of cerebrotendinous xanthomatosis. 2023. https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=300510. Accessed February 2, 2023."},{"issue":"2","key":"10.1016\/j.jacl.2023.07.002_bib0011","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmhg.2013.01.002","article-title":"Consanguinity and its relevance to clinical genetics","volume":"14","author":"Shawky","year":"2013","journal-title":"Egypt J Med Hum Genet"},{"issue":"1","key":"10.1016\/j.jacl.2023.07.002_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.1320310104","article-title":"Pregnancy in women with cerebrotendinous xanthomatosis (CTX): high risk condition for fetus and newborn infant?","volume":"31","author":"Berginer","year":"1988","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.jacl.2023.07.002_bib0013","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/WNF.0b013e318288076a","article-title":"Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis","volume":"36","author":"Yahalom","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jacl.2023.07.002_bib0014","series-title":"Chenodal\u2122 250 Mg (chenodiol tablets) [prescribing information]","year":"2009"},{"issue":"7836","key":"10.1016\/j.jacl.2023.07.002_bib0015","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(73)91110-0","article-title":"Letter: pathological changes in fetal rhesus monkey induced by oral chenodeoxycholic acid","volume":"302","author":"Heywood","year":"1973","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jacl.2023.07.002_bib0016","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000658-197610000-00012","article-title":"Chenodeoxycholic acid induced liver injury in pregnant and neonatal baboons","volume":"184","author":"McSherry","year":"1976","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.jacl.2023.07.002_bib0017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gut.17.6.405","article-title":"Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. serum levels of sulphated and unsulphated lithocholates","volume":"17","author":"Allan","year":"1976","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jacl.2023.07.002_bib0018","first-page":"149","article-title":"Chenodeoxycholic acid (CDCA) versus ursodeoxycholic acid (UDCA): a comparison of their effects in pregnant rats","volume":"246","author":"Celle","year":"1980","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.jacl.2023.07.002_bib0019","unstructured":"CTX Alliance. CTX Alliance - Cerebrotendinous Xanthomatosis (CTX). Providing education, support, advocacy, and promoting research for CTX patients, their families, and medical professionals who treat and study this rare disease. 2023. https:\/\/ctxalliance.org. (Accessed 14 June 2023)."}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742300226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742300226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:39:57Z","timestamp":1761831597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742300226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S193328742300226X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2023.07.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of cerebrotendinous xanthomatosis in pregnancy: Patient and physician perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2023.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}